Form 4: Arcus Biosciences Director Discloses Stock Transactions

Arcus Biosciences Director Antoni Ribas reported transactions involving common stock, including a gift and the disposition of shares.

Summary

• Antoni Ribas, a Director at Arcus Biosciences, Inc. (RCUS), reported a transaction on December 16, 2025.
• The transaction involved the disposition of 5,050 shares of common stock, marked as a gift (Code G).
• Following this transaction, Mr. Ribas beneficially owns 38,600 shares of common stock directly.
• Additionally, 8,553 shares are held indirectly through a trust.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this filing as neutral, as it represents a standard disclosure of insider transactions without significant positive or negative implications for the company's performance.

Positives

• The reporting person, Antoni Ribas, continues to hold a significant number of shares (38,600 directly and 8,553 indirectly).
• The disposition of shares was a gift, potentially for estate planning, which can be a positive indicator of long-term family wealth management.

Negatives

• A disposition of 5,050 shares occurred, reducing the reporting person's direct ownership.

Risks

• The filing does not explicitly mention any risks or future challenges.

Future Outlook

No forward-looking statements or guidance are present in this Form 4 filing.

Industry Context

StockSavvy.ai notes that Form 4 filings are standard disclosures for insider transactions and do not typically contain strategic updates. This filing indicates a routine personal financial transaction by a director.

Related Party Transactions

• The disposition of 5,050 shares was a gift to family members for estate planning purposes.

Stakeholder Impact

• Shareholders: The transaction is a personal financial matter for the director and is not expected to have a direct impact on the company's share price or operations.

Next Steps

• No specific next steps are mentioned in this filing.

Key Dates

Keywords

Arcus Biosciences, RCUS, Form 4, SEC Filing, Insider Trading, Stock Transaction, Director, Beneficial Ownership, Common Stock, Gift